55 related articles for article (PubMed ID: 29813017)
1. Corrigendum: Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Jul; 164(7):1004. PubMed ID: 29813017
[No Abstract] [Full Text] [Related]
2. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
[TBL] [Abstract][Full Text] [Related]
3. Conformational plasticity of SpyCas9 induced by AcrIIA4 and AcrIIA2: Insights from molecular dynamics simulation.
Wen S; Zhao Y; Qi X; Cai M; Huang K; Liu H; Kong DX
Comput Struct Biotechnol J; 2024 Dec; 23():537-548. PubMed ID: 38235361
[TBL] [Abstract][Full Text] [Related]
4. Tuning CRISPR-Cas9 Gene Drives in
Roggenkamp E; Giersch RM; Schrock MN; Turnquist E; Halloran M; Finnigan GC
G3 (Bethesda); 2018 Mar; 8(3):999-1018. PubMed ID: 29348295
[TBL] [Abstract][Full Text] [Related]
5. Use of anti-CRISPR protein AcrIIA4 as a capture ligand for CRISPR/Cas9 detection.
Johnston RK; Seamon KJ; Saada EA; Podlevsky JD; Branda SS; Timlin JA; Harper JC
Biosens Bioelectron; 2019 Sep; 141():111361. PubMed ID: 31207570
[TBL] [Abstract][Full Text] [Related]
6. Large fragment deletion using a CRISPR/Cas9 system in Saccharomyces cerevisiae.
Hao H; Wang X; Jia H; Yu M; Zhang X; Tang H; Zhang L
Anal Biochem; 2016 Sep; 509():118-123. PubMed ID: 27402178
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 Genome Engineering in Saccharomyces cerevisiae Cells.
Ryan OW; Poddar S; Cate JH
Cold Spring Harb Protoc; 2016 Jun; 2016(6):. PubMed ID: 27250940
[TBL] [Abstract][Full Text] [Related]
8. Improved bioethanol production using CRISPR/Cas9 to disrupt the ADH2 gene in Saccharomyces cerevisiae.
Xue T; Liu K; Chen D; Yuan X; Fang J; Yan H; Huang L; Chen Y; He W
World J Microbiol Biotechnol; 2018 Oct; 34(10):154. PubMed ID: 30276556
[TBL] [Abstract][Full Text] [Related]
9. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
Numamoto M; Maekawa H; Kaneko Y
J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
[TBL] [Abstract][Full Text] [Related]
10. Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
Bubeck F; Hoffmann MD; Harteveld Z; Aschenbrenner S; Bietz A; Waldhauer MC; Börner K; Fakhiri J; Schmelas C; Dietz L; Grimm D; Correia BE; Eils R; Niopek D
Nat Methods; 2018 Nov; 15(11):924-927. PubMed ID: 30377362
[TBL] [Abstract][Full Text] [Related]
11. Safeguarding CRISPR-Cas9 gene drives in yeast.
DiCarlo JE; Chavez A; Dietz SL; Esvelt KM; Church GM
Nat Biotechnol; 2015 Dec; 33(12):1250-1255. PubMed ID: 26571100
[TBL] [Abstract][Full Text] [Related]
12. CAR1 deletion by CRISPR/Cas9 reduces formation of ethyl carbamate from ethanol fermentation by Saccharomyces cerevisiae.
Chin YW; Kang WK; Jang HW; Turner TL; Kim HJ
J Ind Microbiol Biotechnol; 2016 Nov; 43(11):1517-1525. PubMed ID: 27573438
[TBL] [Abstract][Full Text] [Related]
13. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
14. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
Giersch RM; Finnigan GC
Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
[TBL] [Abstract][Full Text] [Related]
16. Dramatic Improvement of CRISPR/Cas9 Editing in
Ng H; Dean N
mSphere; 2017; 2(2):. PubMed ID: 28435892
[TBL] [Abstract][Full Text] [Related]
17. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae.
Mans R; van Rossum HM; Wijsman M; Backx A; Kuijpers NG; van den Broek M; Daran-Lapujade P; Pronk JT; van Maris AJ; Daran JM
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25743786
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR/Cas9 method to generate heterozygous alleles in Saccharomyces cerevisiae.
EauClaire SF; Webb CJ
Yeast; 2019 Oct; 36(10):607-615. PubMed ID: 31301239
[TBL] [Abstract][Full Text] [Related]
20. Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity.
Seamon KJ; Light YK; Saada EA; Schoeniger JS; Harmon B
Anal Chem; 2018 Jun; 90(11):6913-6921. PubMed ID: 29756770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
